Jiaherb Adopts Rhodiola Through ABC's Adopt-an-Herb Program: Company's commitment supports ABC's educational mission and HerbMedPro database.
The American Botanical Council (ABC), Austin, TX, welcomed the adoption of rhodiola (Rhodiola rosea) by Jiaherb Inc., a manufacturer and supplier of natural and botanical ingredients, through ABC's Adopt-an-Herb Program. With its adoption, Jiaherb helps ABC expand its non-profit educational mission and keep its HerbMedPro database updated with the latest scientific and clinical research on this traditionally used medicinal plant.HerbMedPro is a comprehensive, interactive online database that provides access to important scientific and clinical research data on the uses and health effects of approximately 250 medicinal and aromatic plants.
"By supporting the Adopt-an-Herb Program, we will be working together with ABC to do further research on the benefits of this increasingly popular botanical," said Scott Chen, president of Jiaherb. "This will help to educate the global herb community, including the botanical industry, about rhodiola, rhodiola's traditional use, current applications, and sustainable development."
"ABC is deeply grateful to Jiaherb for its generous support of ABC's non-profit educational mission via their adoption of Rhodiola rosea," said Mark Blumenthal, founder and executive director of ABC. "There is increasing research and market interest in this adaptogenic root and its extracts, and ABC will be able to stay current with the scientific and clinical research on this important herb due to Jiaherb's adoption."
Mr. Chen noted that sustainability concerns for Rhodiola rosea have made research and conservation efforts particularly important. "In recent years, the sources of rhodiola have started to slowly diminish," he said. "It is time for us to shift our attention to the sustainability of this naturally grown herb and its scientific use and benefits. We need to develop a sustainable future for rhodiola that will protect it from overharvesting, and to implement a solution that will protect the species from extinction."
Rhodiola, also known as golden root, arctic root, and roseroot, grows naturally at high altitudes and in arctic regions of Europe, North America, and Asia. Although it has long been used in traditional medicine for several disorders, it is mostly known as an adaptogenic herb used to help prevent and treat stress, mental and physical fatigue, depression, and to boost energy.
In Russia and Scandinavia, rhodiola has been used for centuries to cope with the cold Siberian climate and stressful life. It is also used to increase physical endurance and resistance to altitude sickness. The plant has been used in traditional Chinese medicine, where it is called hong jing tian. Scientists have identified about 140 chemical compounds in the roots of rhodiola, including phenols, rosavin, rosin, rosarin, organic acids, terpenoids, phenolcarbonic acids and derivatives thereof, and flavonoids.
www.herbalgram.org; www.jiaherbinc.com
Study Finds Vitamins K2 & D Essential for Children's Bone Health
The Journal of the American College of Nutrition has published a review paper that highlights the impact of correcting nutritional insufficiencies, most importantly vitamin K2 in combination with vitamin D and calcium, leading to a significantly less incidence of low-energy bone fractures in children and young adults.
According to Dr. Vladimir Badmaev, author of the paper and principal and founder of American Medical Holdings, Inc., "The epidemiological evidence indicates a disturbing growth in the number of cases of low-energy fractures in healthy children and adolescents. There are multiple risk factors that may contribute to this growing health concern, and deficient or insufficient nutrition and nutrients, including calcium, vitamin D, and vitamin K are among leading considerations."
Dr. Badmaev led an international research consortium with representatives in the U.S. and Poland to review the expansive body of research (epidemiological and human clinical) that shows environmental and nutritional factors that contribute to children's bone health, the mechanisms and biological roles by which nutrients contribute to bone health in children and young adults, and the status of nutrient insufficiency and deficiency of these nutrients.
Dr. Badmaev explained that the particular role of vitamin K2, especially menaquinone-7 (MK-7), has been highlighted in the literature recently and distinguished from vitamin K1 in maintaining calcium homeostasis and a healthy skeletal system. "The epidemiological and clinical research provides a new nutritional paradigm for efficient and safe delivery of calcium that requires co-supplementation with both fat-soluble vitamins D and K."
"This review is so very significant providing supporting evidence to the clinical research NattoPharma has already spearheaded," said Dr. Hogne Vik, chief medical officer with NattoPharma ASA. "Not only has our research identified children as a group most deficient in vitamin K2, but that just 45 mcg of K2 (as NattoPharma's MenaQ7) daily improves K status and increases the activation of osteocalcin, the K-dependent protein responsible for binding calcium to the bone mineral matrix, therefore improving bone health."
Dr. Badmaev concluded, "The new proposed nutritional regimen may not only prevent low-energy fractures among children and young adults, but will also contribute to building the 'bone bank,' therefore helping to prevent development of osteoporosis later in life and prevent untoward cardiovascular risk."
www.naffopharma.com
Bilberry Extract Offers Support from Dry Eye
A new randomized, double-blinded, placebo-controlled clinical study published in European Review for Medical and Pharmacological Sciences (Riva A. et al, 2017) highlighted that Mirtoselect, a proprietary, standardized bilberry extract containing 36% anthocyanins from Indena, may have an important role in preserving adequate aqueous levels in people possibly experiencing dry eye conditions.
The aim of the study was to investigate the ability of bilberry extract to maintain adequate tear levels and to confirm its antioxidant potential. Twenty-one healthy subjects experiencing dry eye were enrolled and randomly assigned to receive Mirtoselect supplementation (two tablets corresponding to 160 mg) daily or placebo for four weeks. The results of Schimer's test indicating the volume of tear secretion before and after the four-week period showed significant improvements in the mean values for right eye (+71%, p=0.009) and both eyes (+55% p=0.019) as well as a beneficial tendency for the left eye (+43%, p=0.062) in the supplemented group. In the placebo group, the mean values of Schimer's test at the end of the treatment were not significant.
"Aged people or those exposed to certain stress conditions for the eye (i.e., dust or dry environment) may experience discomfort, visual disturbance, and tear film instability with potential impairment of the ocular surface (Dry Eye Workshop (DEWS) DED definition, 2017.)," commented Antonella Riva, product research manager at Indena. "Mirtoselect is supported by a strong clinical literature, confirming its efficacy profile in the realm of vascular health and ophthalmology. This last study opens a new application for our bilberry extract in subjects with visual fatigue and a higher tendency of dry eye. The observed antioxidant potential is of a great importance due to the fact that a potential relationship between dry eye and relative oxygen species is reported."
www.us.indena.com
 Printer friendly
 Cite/link
 Email
 Feedback
| |
| Title Annotation: | Suppliers Corner |
|---|---|
| Publication: | Nutraceuticals World |
| Date: | Oct 1, 2017 |
| Words: | 1099 |
| Previous Article: | Blue Guard Blue Light Defense Formula Designed to Protect Eyes: Supplement created to help millennials shield their eyes from harmful effects of blue... |
| Next Article: | Calendar of Events. |
| Topics: | |